What does CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE do?

CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE is a specialist medical practice in Mons. Private Limited, started on 13 February 2013, 1 establishment.

What is the address of CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE?

The registered office of CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE is located at Chemin Bouteiller(G.) 2 box A, 7011 Mons.

Is CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE still active?

Yes. According to the CBE (30 September 2026) CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE is active, legal situation “Normale toestand”, started on 13 February 2013.

Is CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE registered on Peppol?

Yes, CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE is registered on the Peppol network with ID 0208:0504902717.

What is the enterprise number of CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE?

The enterprise number of CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE is BE0504902717.

Who are the directors of CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE?

According to the 2025 annual accounts, the directors of CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE are: ISABELLE SINAPI.

Is CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 February 2013; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE make in 2025?

CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE posted a profit after taxes of € 32,978 in financial year 2025.

What is the revenue of CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE?

As a small company, CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 47,921.

CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE (Private Limited)

Q: When was CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE founded?

CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE was founded on 13 February 2013.

Dossier CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE, printed on 30 September 2026 from databakkes.be/en/0504902717/cabinet-medical-d-oncologie-dr-sinapi-isabelle. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE from Mons, company number BE0504902717, closed financial year 2025 with a result of € 32,978 after tax. For that financial year CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE recorded a gross margin of € 47,921 and equity of € 233,049. Compared with financial year 2024, the result moved from € 24,709 to € 32,978. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Growing

€ 233,049

▲ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 32,978

▲ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 151,421

▲ 4% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 220,649.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 4,276

▲ 42% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 35,810 Gross margin 2022: € 35,810 First fiscal year in the series	€ 36,364 Gross margin 2023: € 36,364 ▲ 2% vs 2022 (€ 35,810) Favourable step	€ 36,212 Gross margin 2024: € 36,212 Unchanged (€ 36,364) Unfavourable step	€ 47,921 Gross margin 2025: € 47,921 ▲ 32% vs 2024 (€ 36,212) Favourable step	▲ 32%
Profit after taxes	€ 25,052 Profit after taxes 2022: € 25,052 First fiscal year in the series	€ 24,687 Profit after taxes 2023: € 24,687 ▼ 1% vs 2022 (€ 25,052) Unfavourable step	€ 24,709 Profit after taxes 2024: € 24,709 Unchanged (€ 24,687) Favourable step	€ 32,978 Profit after taxes 2025: € 32,978 ▲ 33% vs 2024 (€ 24,709) Favourable step	▲ 33%
Equity	€ 172,267 Equity 2022: € 172,267 First fiscal year in the series	€ 175,362 Equity 2023: € 175,362 ▲ 2% vs 2022 (€ 172,267) Favourable step	€ 200,072 Equity 2024: € 200,072 ▲ 14% vs 2023 (€ 175,362) Favourable step	€ 233,049 Equity 2025: € 233,049 ▲ 16% vs 2024 (€ 200,072) Favourable step	▲ 16%
Total debts	€ 13,410 Total debts 2022: € 13,410 First fiscal year in the series	€ 20,995 Total debts 2023: € 20,995 ▲ 57% vs 2022 (€ 13,410) Unfavourable step	€ 11,538 Total debts 2024: € 11,538 ▼ 45% vs 2023 (€ 20,995) Favourable step	€ 15,984 Total debts 2025: € 15,984 ▲ 39% vs 2024 (€ 11,538) Unfavourable step	▲ 39%
Cash	€ 125,437 Cash 2022: € 125,437 First fiscal year in the series	€ 122,877 Cash 2023: € 122,877 ▼ 2% vs 2022 (€ 125,437) Unfavourable step	€ 145,733 Cash 2024: € 145,733 ▲ 19% vs 2023 (€ 122,877) Favourable step	€ 151,421 Cash 2025: € 151,421 ▲ 4% vs 2024 (€ 145,733) Favourable step	▲ 4%
Retained profit	€ 159,867 Retained profit 2022: € 159,867 First fiscal year in the series	€ 162,962 Retained profit 2023: € 162,962 ▲ 2% vs 2022 (€ 159,867) Favourable step	€ 187,672 Retained profit 2024: € 187,672 ▲ 15% vs 2023 (€ 162,962) Favourable step	€ 220,649 Retained profit 2025: € 220,649 ▲ 18% vs 2024 (€ 187,672) Favourable step	▲ 18%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 21,592 Dividend 2023: € 21,592 ▲ € 20,792 vs 2022 (€ 800) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 21,592) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 185,677 Balance sheet total 2022: € 185,677 First fiscal year in the series	€ 196,357 Balance sheet total 2023: € 196,357 ▲ 6% vs 2022 (€ 185,677) Unchanged	€ 211,610 Balance sheet total 2024: € 211,610 ▲ 8% vs 2023 (€ 196,357) Unchanged	€ 249,034 Balance sheet total 2025: € 249,034 ▲ 18% vs 2024 (€ 211,610) Unchanged	▲ 18%

Key figures of CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE?

What happened at CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 32,978 (▲ 33% vs 2024). Source: NBB ↗
Feb 13, 2013 New establishment in Courcelles. KBO
Feb 13, 2013 Start of the company according to the CBE. KBO

In short

From € 25,052 profit in 2022 to € 32,978 profit in 2025.

Paid € 44,033 in corporate taxes since 2022.

Best year ever: 2025, with € 32,978 profit.

Paid out € 22,392 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE? We notify you, reason included.

Follow CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ISABELLE SINAPI

CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE

Behind CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE is ISABELLE SINAPI.

See the full network in the app

Directors

According to the 2025 annual accounts

ISABELLE SINAPI

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin Bouteiller(G.) 2 box A

7011 Mons

2.217.266.283

Rue de la Baille(CO) 12 box B

6180 Courcelles

Active since 13 February 2013

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0504.902.717

VAT number

BE 0504.902.717

Registered office

Chemin Bouteiller(G.) 2 bus A, 7011 Mons

Names & denominations

CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

13 February 2013

Peppol

Active · Active since 6 Mar 2026

Contact

[email protected] 0478/597262

Activities · NACE

Activiteiten van medisch specialisten

Beroepsopleiding

View on CBE Public ↗ Annual accounts (NBB) ↗

CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE

Financials

What happened to CABINET MEDICAL D'ONCOLOGIE DR SINAPI ISABELLE?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions